Editorial: Therapeutic potential of the cannabinoid CB2 receptor
Main Authors: | Reem Smoum, Uwe Grether, Meliha Karsak, Andrea J. Vernall, Frank Park, Cecilia J. Hillard, Pal Pacher |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1039564/full |
Similar Items
-
Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
by: Antonella Capozzi, et al.
Published: (2021-12-01) -
Role of CB2 cannabinoid receptor in the development of food addiction in male mice
by: A. García-Blanco, et al.
Published: (2023-04-01) -
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
by: Marcel Pérez-Morales, et al.
Published: (2025-02-01) -
Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model
by: Erika Cottone, et al.
Published: (2021-03-01) -
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)
by: Rebecca Ferrisi, et al.
Published: (2022-09-01)